Relevant research on HERC3 in terms of cancers is rare, and HERC3 was once reported to affect SMAD7 ubiquitination degradation and induce the autophagy–mediated epithelial–mesenchymal transition (EMT) and chemoresistance in glioblastomas [18]. Here, HERC3 is linked to glioblastoma.